Sullivan & Cromwell Advises Agilent On $950M Biocare Buy
Agilent Technologies Inc. agreed to acquire Biocare Medical, a specialist in clinical and research pathology solutions, in an all-cash transaction valued at $950 million, the company said Monday....To view the full article, register now.
Already a subscriber? Click here to view full article